Cancer Vaccines

World Vaccine Market Offers Promise of Growth Exceeding $15 Billion in 2012!

Published in Cancer Weekly, March 6th, 2007

While the world holds its breath waiting for "the cure," new vaccines currently in the development pipeline are emerging as promising alternatives to prevent or mitigate diseases. Globally, the vaccine market is expected to reach more than $10 billion in 2007, according to Vaccines: The World Market, a new report from medical market research firm Kalorama Information.

Expectations are high as numerous vaccines for HIV, several forms of cancer, and other diseases including Epstein-Barr virus, Hepatitis C, and herpes are already in various stages of testing. As many as five new vaccines to treat cancer may soon be available, creating an $8 billion dollar cancer vaccine...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2007-03-06)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry